Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Hutton

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
The New Zealand Medical Journal|April 5, 2005
Responsible IVF treatment in New Zealand is the preferential transfer of a single embryoAndrew Murray, John Hutton, John Peek
International Journal of Technology Assessment in Health Care|October 3, 2008
Harmonization of evidence requirements for health technology assessment in reimbursement decision makingJohn Hutton, Paul Trueman, Karen Facey
Health Economics|December 17, 2002
Safety behind the veil of ignoranceJohn Hutton, Andrew Jones, Alan Maynard
International Journal of Technology Assessment in Health Care|October 17, 2007
Coverage with evidence development: an examination of conceptual and policy issuesJohn Hutton, Paul Trueman, Christopher Henshall
International Journal of Technology Assessment in Health Care|May 8, 2012
A comparison of pharmaceutical reimbursement agencies' processes and methods in France and ScotlandMatthew Bending, John Hutton, Clare McGrath
Health Policy (Amsterdam, Netherlands)|May 15, 2003
Selecting methods for the prediction of future events in cost-effectiveness models: a decision-framework and example from the cardiovascular fieldRichard Grieve, John Hutton, Colin Green
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 5, 2002
Cost-effectiveness analysis of interferon beta in multiple sclerosis: a Markov process analysisMark J C Nuijten, John Hutton
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 29, 2002
Development of a decision-analytic model of stroke care in the United States and EuropeMichael G Chambers, Peter Koch, John Hutton
International Journal of Technology Assessment in Health Care|October 23, 2009
The feasibility of harmonizing health technology assessments across jurisdictions: a case study of drug eluting stentsPaul Trueman, Manjusha Hurry, Matthew Bending, et al.
Pharmacoeconomics|November 29, 2002
Developing the revised NICE appraisal technical guidance to manufacturers and sponsors: opportunity or threat?Rod S Taylor, John Hutton, Anthony J Culyer
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
The New Zealand Medical Journal|April 5, 2005
Responsible IVF treatment in New Zealand is the preferential transfer of a single embryoAndrew Murray, John Hutton, John Peek
International Journal of Technology Assessment in Health Care|October 3, 2008
Harmonization of evidence requirements for health technology assessment in reimbursement decision makingJohn Hutton, Paul Trueman, Karen Facey
Health Economics|December 17, 2002
Safety behind the veil of ignoranceJohn Hutton, Andrew Jones, Alan Maynard
International Journal of Technology Assessment in Health Care|October 17, 2007
Coverage with evidence development: an examination of conceptual and policy issuesJohn Hutton, Paul Trueman, Christopher Henshall
International Journal of Technology Assessment in Health Care|May 8, 2012
A comparison of pharmaceutical reimbursement agencies' processes and methods in France and ScotlandMatthew Bending, John Hutton, Clare McGrath
Health Policy (Amsterdam, Netherlands)|May 15, 2003
Selecting methods for the prediction of future events in cost-effectiveness models: a decision-framework and example from the cardiovascular fieldRichard Grieve, John Hutton, Colin Green
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 5, 2002
Cost-effectiveness analysis of interferon beta in multiple sclerosis: a Markov process analysisMark J C Nuijten, John Hutton
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 29, 2002
Development of a decision-analytic model of stroke care in the United States and EuropeMichael G Chambers, Peter Koch, John Hutton
International Journal of Technology Assessment in Health Care|October 23, 2009
The feasibility of harmonizing health technology assessments across jurisdictions: a case study of drug eluting stentsPaul Trueman, Manjusha Hurry, Matthew Bending, et al.
Pharmacoeconomics|November 29, 2002
Developing the revised NICE appraisal technical guidance to manufacturers and sponsors: opportunity or threat?Rod S Taylor, John Hutton, Anthony J Culyer
Pageof 6